Tumor Budding as an Independent Prognostic Factor for Stage III Colon Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Tumor budding is an independent prognostic factor in stage III colon cancer patients: A post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR)
Ann. Oncol 2022 Mar 16;[EPub Ahead of Print], D Basile, C Broudin, JF Emile, A Falcoz, F Pagès, L Mineur, J Bennouna, C Louvet, P Artru, S Fratte, F Ghiringhelli, T André, V Derangère, D Vernerey, J Taieb, M SvrcekFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.